Pharmafile Logo
Pharmafocus logo
Advanced Search

meningococcal disease

Showing 3 posts of 3 posts found.

Sanofi’s Meningococcal Conjugate Vaccine secures FDA approval in patients aged two and up

April 27, 2020
Sales and Marketing FDA, MenQuadfi, Sanofi, US, meningococcal disease, pharma

Sanofi’s MedQuadfi Meningococcal Conjugate Vaccine has scored FDA approval for the prevention of invasive meningococcal disease, becoming the first and …

News
pfizerbrussels

Pfizer presents positive results in meningococcal disease late-stage trials

May 13, 2016
Research and Development Pfizer, Vaccine, late stage trials, meningococcal disease

Pfizer (NYSE: PFE) has announced results from two pivotal late-stage trials demonstrating the immunogenicity of Trumenba against invasive meningococcal B …

News

Novartis submits meningococcal vaccine Bexsero for European approval

December 23, 2010
Sales and Marketing Bexsero, MenB, Novartis, Vaccine, bacterial meningitis, bloodstream infection sepsis, meningococcal disease, meningococcal vaccine

Novartis has submitted its meningococcal vaccine Bexsero to European regulators for marketing approval. If approved the drug will be the …

News

Latest content

Ardena announces €20m expansion following first GMP approval

April 19, 2024

Roche’s Alecensa approved by FDA as lung cancer treatment

April 19, 2024

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024

Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity

April 18, 2024

Medincell and AbbVie enter agreement for development of next-generation injectables

April 17, 2024